Solventum Corporation (SOLV) Gross Margin: 53.67%
Is Solventum Corporation’s gross margin high or low?
Solventum Corporation's gross margin of 53.67% is in line with its 5-year average of 57.27%, near the low end of its 5-year range (53.47%–60.25%).
As of Friday, June 12, 2026. 1.63% below its 12-month average of 54.56%.
SOLV Gross Margin Chart
SOLV Average Gross Margin Chart
SOLV Current vs Average Gross Margin Chart
SOLV Gross Margin Metrics
GROSS MARGIN
53.67%
GROSS MARGIN AVG TTM
54.56%
GROSS MARGIN AVG 3Y
56.03%
GROSS MARGIN AVG 5Y
57.27%
GROSS MARGIN AVG 10Y
57.27%
GROSS MARGIN AVG 15Y
57.27%
GROSS MARGIN AVG 20Y
57.27%
CURRENT VS TTM AVG
-1.63%
CURRENT VS 3Y AVG
-4.21%
CURRENT VS 5Y AVG
-6.29%
CURRENT VS 10Y AVG
-6.29%
CURRENT VS 15Y AVG
-6.29%
CURRENT VS 20Y AVG
-6.29%
SOLV Competitors' Gross Margin
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 53.67% | 54.56% | 56.03% | 57.27% |
| Align Technology, Inc. (ALGN) | $12.64B | 67.68% | 69.16% | 69.73% | 70.75% |
| Baxter International Inc. (BAX) | $10.70B | 30.11% | 33.76% | 35.72% | 36.84% |
| Hologic, Inc. (HOLX) | $16.97B | 52.82% | 58.14% | 57.33% | 59.28% |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 31.86% | 31.70% | 34.15% | 35.17% |
| Tempus AI, Inc. (TEM) | $8.65B | 69.55% | 62.30% | 54.75% | 44.45% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 51.87% | 52.87% | 53.77% | 54.60% |
| Moderna, Inc. (MRNA) | $19.70B | -13.89% | 54.80% | 53.09% | 65.45% |
| Hims & Hers Health, Inc. (HIMS) | $6.44B | 67.64% | 76.65% | 78.21% | 76.94% |
| BioNTech SE (BNTX) | $22.52B | 73.26% | 78.98% | 81.24% | 82.89% |
Gross Margin Analysis
Gross Margin
53.7%
(Revenue - COGS) / Revenue
Solventum Corporation Gross Margin Formula & Definition
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation Gross Margin FAQ
- What is the gross margin for Solventum Corporation (SOLV)?
- The gross margin for SOLV stock is 53.67%.
- Is Solventum Corporation's gross margin high or low?
- Solventum Corporation's gross margin of 53.67% is in line with its 5-year average of 57.27%, near the low end of its 5-year range (53.47%–60.25%).
- What is the TTM average gross margin for Solventum Corporation (SOLV)?
- The TTM average gross margin for SOLV stock is 54.56%.
- What is the 3Y average gross margin for Solventum Corporation (SOLV)?
- The 3Y average gross margin for SOLV stock is 56.03%.
- What is the 5Y average gross margin for Solventum Corporation (SOLV)?
- The 5Y average gross margin for SOLV stock is 57.27%.
- What is the 10Y average gross margin for Solventum Corporation (SOLV)?
- The 10Y average gross margin for SOLV stock is 57.27%.
- What is the 15Y average gross margin for Solventum Corporation (SOLV)?
- The 15Y average gross margin for SOLV stock is 57.27%.
- What is the 20Y average gross margin for Solventum Corporation (SOLV)?
- The 20Y average gross margin for SOLV stock is 57.27%.
Solventum Corporation Gross Margin History
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | 53.47% |
| 2024-12-31 | 55.65% |
| 2023-12-31 | 57.25% |
| 2022-12-31 | 57.75% |
| 2021-12-31 | 60.25% |
| 2020-12-31 | 59.26% |
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson